TY - JOUR
T1 - Population based audit of heart radiation doses in 6925 high-risk breast cancer patients from the Danish breast cancer group RT Nation study
AU - Buhl, Emma Skarsø
AU - Refsgaard, Lasse Hindhede
AU - Al-Rawi, Sami Aziz-Jowad
AU - Andersen, Karen
AU - Berg, Martin
AU - Boye, Kristian
AU - Jensen, Ingelise
AU - Lorenzen, Ebbe Laugaard
AU - Maae, Else
AU - Maraldo, Maja Vestmø
AU - Matthiessen, Louise Wichmann
AU - Milo, Marie Louise
AU - Nielsen, Mette Holck
AU - Saini, Abhilasha
AU - Yates, Esben
AU - Offersen, Birgitte Vrou
AU - Korreman, Stine Sofia
N1 - Copyright © 2024. Published by Elsevier B.V.
PY - 2025
Y1 - 2025
N2 - BACKGROUND AND PURPOSE: In this study, we conducted a population-based retrospective audit of heart doses for high-risk breast cancer (BC) over a nine-year period in patients treated with adjuvant CT-based radiotherapy in a comprehensive and homogenized national BC cohort. Additionally, this serves as a demonstration of performing large scale audits with consistent delineations created by an auto-segmentation tool.MATERIALS AND METHODS: High-risk BC patients treated with adjuvant radiotherapy in the period 2008-2016 from all seven radiotherapy centres in Denmark were included. A homogenized cohort was created using an inhouse developed auto-segmentation tool. The homogenized cohort volume and planned doses (mean heart dose (MHD), V20Gy and V40Gy) were evaluated. Volumes and dose metrics were compared for clinical and homogenized heart volumes.RESULTS: Among 6925 patients, 5589(81 %) had a clinical heart delineation. The median delineated heart volume increased from 531.9 ml (2008) to 638.5 ml (2016) (p < 0.01). The median MHD for the homogenized cohort was 1.58 Gy (2008-2016) with an overall decreasing trend, 2.14 Gy in left- and 1.08 Gy in right-sided patients. The median MHD in the clinically delineated hearts was 0.01 Gy lower than the planned median MHD in the homogenized cohort.CONCLUSION: During 2008-2016 the planned heart dose has been low across the population. A volume increase was observed in the clinically delineated hearts, however the median MHD in the homogenized cohort was low, with 1.58 Gy. The study demonstrated the possibilities for full population-based and consistent dose audit by using auto-segmentation tools.
AB - BACKGROUND AND PURPOSE: In this study, we conducted a population-based retrospective audit of heart doses for high-risk breast cancer (BC) over a nine-year period in patients treated with adjuvant CT-based radiotherapy in a comprehensive and homogenized national BC cohort. Additionally, this serves as a demonstration of performing large scale audits with consistent delineations created by an auto-segmentation tool.MATERIALS AND METHODS: High-risk BC patients treated with adjuvant radiotherapy in the period 2008-2016 from all seven radiotherapy centres in Denmark were included. A homogenized cohort was created using an inhouse developed auto-segmentation tool. The homogenized cohort volume and planned doses (mean heart dose (MHD), V20Gy and V40Gy) were evaluated. Volumes and dose metrics were compared for clinical and homogenized heart volumes.RESULTS: Among 6925 patients, 5589(81 %) had a clinical heart delineation. The median delineated heart volume increased from 531.9 ml (2008) to 638.5 ml (2016) (p < 0.01). The median MHD for the homogenized cohort was 1.58 Gy (2008-2016) with an overall decreasing trend, 2.14 Gy in left- and 1.08 Gy in right-sided patients. The median MHD in the clinically delineated hearts was 0.01 Gy lower than the planned median MHD in the homogenized cohort.CONCLUSION: During 2008-2016 the planned heart dose has been low across the population. A volume increase was observed in the clinically delineated hearts, however the median MHD in the homogenized cohort was low, with 1.58 Gy. The study demonstrated the possibilities for full population-based and consistent dose audit by using auto-segmentation tools.
UR - http://www.scopus.com/inward/record.url?scp=85209685219&partnerID=8YFLogxK
U2 - 10.1016/j.radonc.2024.110643
DO - 10.1016/j.radonc.2024.110643
M3 - Journal article
C2 - 39557125
SN - 0167-8140
VL - 202
JO - Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
JF - Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
M1 - 110643
ER -